Application of Apoptosis to Cancer Treatment - 9 Angebote vergleichen
Bester Preis: € 175,87 (vom 04.06.2016)1
Application of Apoptosis to Cancer Treatment (2005)
EN NW EB
ISBN: 9781402033025 bzw. 1402033028, in Englisch, Springer Netherlands, neu, E-Book.
Lieferung aus: Schweiz, Sofort per Download lieferbar.
Application of Apoptosis to Cancer Treatment, Novel drugs are being developed which interact with the programmed cell death (apoptotic) machinery in cancer cells, thereby causing these cells to commit suicide and to be removed from the body. Research is also directed to investigate why the cancer cells sometimes lose the ability to undergo apoptosis after a certain period of time and methods are being developed to reactivate this cell death process. This book is intended for workers in the field and clinicians as a useful guide of the state of affairs in this exciting field which may offer more effective possibilities for treatment of cancer patients. Mels Sluyser is the Editor of the journals APOPTOSIS and ANTI-CANCER DRUGS. He brings together a collection of papers written by the worlds leading experts in these fields. PDF, 05.12.2005.
Application of Apoptosis to Cancer Treatment, Novel drugs are being developed which interact with the programmed cell death (apoptotic) machinery in cancer cells, thereby causing these cells to commit suicide and to be removed from the body. Research is also directed to investigate why the cancer cells sometimes lose the ability to undergo apoptosis after a certain period of time and methods are being developed to reactivate this cell death process. This book is intended for workers in the field and clinicians as a useful guide of the state of affairs in this exciting field which may offer more effective possibilities for treatment of cancer patients. Mels Sluyser is the Editor of the journals APOPTOSIS and ANTI-CANCER DRUGS. He brings together a collection of papers written by the worlds leading experts in these fields. PDF, 05.12.2005.
2
Application of Apoptosis to Cancer Treatment
~EN NW EB DL
ISBN: 9781402033025 bzw. 1402033028, vermutlich in Englisch, Springer Shop, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, Lagernd.
Novel drugs are being developed which interact with the programmed cell death (apoptotic) machinery in cancer cells, thereby causing these cells to commit suicide and to be removed from the body. Research is also directed to investigate why the cancer cells sometimes lose the ability to undergo apoptosis after a certain period of time and methods are being developed to reactivate this cell death process. This book is intended for workers in the field and clinicians as a useful guide of the state of affairs in this exciting field which may offer more effective possibilities for treatment of cancer patients. Mels Sluyser is the Editor of the journals APOPTOSIS and ANTI-CANCER DRUGS. He brings together a collection of papers written by the world’s leading experts in these fields. eBook.
Novel drugs are being developed which interact with the programmed cell death (apoptotic) machinery in cancer cells, thereby causing these cells to commit suicide and to be removed from the body. Research is also directed to investigate why the cancer cells sometimes lose the ability to undergo apoptosis after a certain period of time and methods are being developed to reactivate this cell death process. This book is intended for workers in the field and clinicians as a useful guide of the state of affairs in this exciting field which may offer more effective possibilities for treatment of cancer patients. Mels Sluyser is the Editor of the journals APOPTOSIS and ANTI-CANCER DRUGS. He brings together a collection of papers written by the world’s leading experts in these fields. eBook.
3
Application of Apoptosis to Cancer Treatment (2010)
NL PB NW
ISBN: 9789048168330 bzw. 9048168333, in Holländisch, Springer, Taschenbuch, neu.
Lieferung aus: Niederlande, 3-4 weken.
bol.com.
Novel drugs are being developed which interact with the programmed cell death (apoptotic) machinery in cancer cells, thereby causing these cells to commit suicide and to be removed from the body. Research is also directed to investigate why the cancer cells sometimes lose the ability to undergo apoptosis after a certain period of time and methods are being developed to reactivate this cell death process. This book is intended for workers in the field and clinicians as a useful guide of the state... Novel drugs are being developed which interact with the programmed cell death (apoptotic) machinery in cancer cells, thereby causing these cells to commit suicide and to be removed from the body. Research is also directed to investigate why the cancer cells sometimes lose the ability to undergo apoptosis after a certain period of time and methods are being developed to reactivate this cell death process. This book is intended for workers in the field and clinicians as a useful guide of the state of affairs in this exciting field which may offer more effective possibilities for treatment of cancer patients. Mels Sluyser is the Editor of the journals APOPTOSIS and ANTI-CANCER DRUGS. He brings together a collection of papers written by the world's leading experts in these fields. Productinformatie:Taal: Engels;Afmetingen: 19x234x156 mm;Gewicht: 532,00 gram;ISBN10: 9048168333;ISBN13: 9789048168330; Engels | Paperback | 2010.
bol.com.
Novel drugs are being developed which interact with the programmed cell death (apoptotic) machinery in cancer cells, thereby causing these cells to commit suicide and to be removed from the body. Research is also directed to investigate why the cancer cells sometimes lose the ability to undergo apoptosis after a certain period of time and methods are being developed to reactivate this cell death process. This book is intended for workers in the field and clinicians as a useful guide of the state... Novel drugs are being developed which interact with the programmed cell death (apoptotic) machinery in cancer cells, thereby causing these cells to commit suicide and to be removed from the body. Research is also directed to investigate why the cancer cells sometimes lose the ability to undergo apoptosis after a certain period of time and methods are being developed to reactivate this cell death process. This book is intended for workers in the field and clinicians as a useful guide of the state of affairs in this exciting field which may offer more effective possibilities for treatment of cancer patients. Mels Sluyser is the Editor of the journals APOPTOSIS and ANTI-CANCER DRUGS. He brings together a collection of papers written by the world's leading experts in these fields. Productinformatie:Taal: Engels;Afmetingen: 19x234x156 mm;Gewicht: 532,00 gram;ISBN10: 9048168333;ISBN13: 9789048168330; Engels | Paperback | 2010.
4
Application of Apoptosis to Cancer Treatment (2010)
EN PB NW
ISBN: 9789048168330 bzw. 9048168333, in Englisch, 380 Seiten, Springer Netherlands, Taschenbuch, neu.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, Usually dispatched within 1-2 business days.
Von Händler/Antiquariat, UKPaperbackshop.
Novel drugs are being developed which interact with the programmed cell death (apoptotic) machinery in cancer cells, thereby causing these cells to commit suicide and to be removed from the body. Research is also directed to investigate why the cancer cells sometimes lose the ability to undergo apoptosis after a certain period of time and methods are being developed to reactivate this cell death process. This book is intended for workers in the field and clinicians as a useful guide of the state of affairs in this exciting field which may offer more effective possibilities for treatment of cancer patients. Mels Sluyser is the Editor of the journals APOPTOSIS and ANTI-CANCER DRUGS. He brings together a collection of papers written by the world's leading experts in these fields. Paperback, Ausgabe: Softcover reprint of hardcover 1st ed. 2005, Label: Springer Netherlands, Springer Netherlands, Produktgruppe: Book, Publiziert: 2010-02-19, Freigegeben: 2010-02-19, Studio: Springer Netherlands.
Von Händler/Antiquariat, UKPaperbackshop.
Novel drugs are being developed which interact with the programmed cell death (apoptotic) machinery in cancer cells, thereby causing these cells to commit suicide and to be removed from the body. Research is also directed to investigate why the cancer cells sometimes lose the ability to undergo apoptosis after a certain period of time and methods are being developed to reactivate this cell death process. This book is intended for workers in the field and clinicians as a useful guide of the state of affairs in this exciting field which may offer more effective possibilities for treatment of cancer patients. Mels Sluyser is the Editor of the journals APOPTOSIS and ANTI-CANCER DRUGS. He brings together a collection of papers written by the world's leading experts in these fields. Paperback, Ausgabe: Softcover reprint of hardcover 1st ed. 2005, Label: Springer Netherlands, Springer Netherlands, Produktgruppe: Book, Publiziert: 2010-02-19, Freigegeben: 2010-02-19, Studio: Springer Netherlands.
5
Application of Apoptosis to Cancer Treatment (2010)
EN PB US
ISBN: 9789048168330 bzw. 9048168333, in Englisch, 380 Seiten, Springer Netherlands, Taschenbuch, gebraucht.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, Usually dispatched within 1-2 business days.
Von Händler/Antiquariat, Herb Tandree Philosophy Books.
Novel drugs are being developed which interact with the programmed cell death (apoptotic) machinery in cancer cells, thereby causing these cells to commit suicide and to be removed from the body. Research is also directed to investigate why the cancer cells sometimes lose the ability to undergo apoptosis after a certain period of time and methods are being developed to reactivate this cell death process. This book is intended for workers in the field and clinicians as a useful guide of the state of affairs in this exciting field which may offer more effective possibilities for treatment of cancer patients. Mels Sluyser is the Editor of the journals APOPTOSIS and ANTI-CANCER DRUGS. He brings together a collection of papers written by the world's leading experts in these fields. Paperback, Ausgabe: Softcover reprint of hardcover 1st ed. 2005, Label: Springer Netherlands, Springer Netherlands, Produktgruppe: Book, Publiziert: 2010-02-19, Freigegeben: 2010-02-19, Studio: Springer Netherlands.
Von Händler/Antiquariat, Herb Tandree Philosophy Books.
Novel drugs are being developed which interact with the programmed cell death (apoptotic) machinery in cancer cells, thereby causing these cells to commit suicide and to be removed from the body. Research is also directed to investigate why the cancer cells sometimes lose the ability to undergo apoptosis after a certain period of time and methods are being developed to reactivate this cell death process. This book is intended for workers in the field and clinicians as a useful guide of the state of affairs in this exciting field which may offer more effective possibilities for treatment of cancer patients. Mels Sluyser is the Editor of the journals APOPTOSIS and ANTI-CANCER DRUGS. He brings together a collection of papers written by the world's leading experts in these fields. Paperback, Ausgabe: Softcover reprint of hardcover 1st ed. 2005, Label: Springer Netherlands, Springer Netherlands, Produktgruppe: Book, Publiziert: 2010-02-19, Freigegeben: 2010-02-19, Studio: Springer Netherlands.
6
Application of Apoptosis to Cancer Treatment
DE NW EB
ISBN: 9781402033025 bzw. 1402033028, in Deutsch, Springer, Niederlande, neu, E-Book.
Lieferung aus: Deutschland, zzgl. Versandkosten, Sofort per Download lieferbar.
Application of Apoptosis to Cancer Treatment, Novel drugs are being developed which interact with the programmed cell death (apoptotic) machinery in cancer cells, thereby causing these cells to commit suicide and to be removed from the body. Research is also directed to investigate why the cancer cells sometimes lose the ability to undergo apoptosis after a certain period of time and methods are being developed to reactivate this cell death process. This book is intended for workers in the field and clinicians as a useful guide of the state of affairs in this exciting field which may offer more effective possibilities for treatment of cancer patients. Mels Sluyser is the Editor of the journals APOPTOSIS and ANTI-CANCER DRUGS. He brings together a collection of papers written by the worlds leading experts in these fields.
Application of Apoptosis to Cancer Treatment, Novel drugs are being developed which interact with the programmed cell death (apoptotic) machinery in cancer cells, thereby causing these cells to commit suicide and to be removed from the body. Research is also directed to investigate why the cancer cells sometimes lose the ability to undergo apoptosis after a certain period of time and methods are being developed to reactivate this cell death process. This book is intended for workers in the field and clinicians as a useful guide of the state of affairs in this exciting field which may offer more effective possibilities for treatment of cancer patients. Mels Sluyser is the Editor of the journals APOPTOSIS and ANTI-CANCER DRUGS. He brings together a collection of papers written by the worlds leading experts in these fields.
7
Application of Apoptosis to Cancer Treatment
EN NW EB
ISBN: 9781402033025 bzw. 1402033028, in Englisch, Springer Netherlands, neu, E-Book.
Lieferung aus: Deutschland, zzgl. Versandkosten.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…